Sukhtian Ghiath M. Insider Trades

Insider Trading History

Track insider trading activity for Sukhtian Ghiath M.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Outlook Therapeutics- Warrants
Outlook Therapeutics- Warrants OTLKW
10% owner
Holding Value $0 0 shares
Last Trade
May 28, 2026 Sale (Expire Long)Reported as Expire Long on SEC Form 4.
$361k 12,029,999 shares
$0.03
$0.03
Outlook Therapeutics- Warrants
Outlook Therapeutics- Warrants OTLKW
10% owner
Holding Value $663k 22,092,068 shares
Last Trade
May 28, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$617k 20,569,708 shares
$0.03
$0.03
Outlook Therapeutics
Outlook Therapeutics OTLK
10% owner
Holding Value $10.8M 13,552,359 shares
Last Trade
May 27, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$20.7M 12,857,142 shares
$1.61
$0.79
Outlook Therapeutics- Warrants
Outlook Therapeutics- Warrants OTLKW
10% owner
Holding Value $407k 13,552,359 shares
Last Trade
May 27, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$386k 12,857,142 shares
$0.03
$0.03
Outlook Therapeutics- Warrants
Outlook Therapeutics- Warrants OTLKW
10% owner
Holding Value $0 0 shares
Last Trade
Jan 17, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$104k 3,458,571 shares
$0.03
$0.03
Outlook Therapeutics
Outlook Therapeutics OTLK
10% owner
Holding Value $2.75M 3,458,571 shares
Last Trade
Jan 17, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.82M 3,458,571 shares
$2.26
$0.79
Outlook Therapeutics- Warrants
Outlook Therapeutics- Warrants OTLKW
10% owner
Holding Value $278k 9,266,645 shares
Last Trade
Jan 17, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$104k 3,458,571 shares
$0.03
$0.03
Outlook Therapeutics- Warrants
Outlook Therapeutics- Warrants OTLKW
10% owner
Holding Value $104k 3,458,571 shares
Last Trade
Jan 17, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$208k 6,917,142 shares
$0.03
$0.03
Outlook Therapeutics- Warrants
Outlook Therapeutics- Warrants OTLKW
10% owner
Holding Value $0 0 shares
Last Trade
Jan 17, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$104k 3,458,571 shares
$0.03
$0.03
Outlook Therapeutics
Outlook Therapeutics OTLK
10% owner
Holding Value $7.37M 9,266,645 shares
Last Trade
Jan 17, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$7.71M 3,458,571 shares
$2.23
$0.79
Outlook Therapeutics- Warrants
Outlook Therapeutics- Warrants OTLKW
10% owner
Holding Value $174k 5,808,074 shares
Last Trade
Mar 18, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$173k 5,764,285 shares
$0.03
$0.03
Outlook Therapeutics
Outlook Therapeutics OTLK
10% owner
Holding Value $4.62M 5,808,074 shares
Last Trade
Mar 18, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$42.8M 5,764,285 shares
$7.42
$0.79
Outlook Therapeutics
Outlook Therapeutics OTLK
Director
Holding Value $55.7M 70,047,204 shares
Last Trade
Dec 28, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$14.4M 14,230,418 shares
$1.01
$0.79
Outlook Therapeutics- Warrants
Outlook Therapeutics- Warrants OTLKW
Director
Holding Value $2.1M 70,047,204 shares
Last Trade
Dec 28, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$427k 14,230,418 shares
$0.03
$0.03
Outlook Therapeutics- Warrants
Outlook Therapeutics- Warrants OTLKW
10% owner
Holding Value $1.67M 55,816,786 shares
Last Trade
Apr 21, 2022 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$839k 27,982,529 shares
$0.03
$0.03
Outlook Therapeutics
Outlook Therapeutics OTLK
10% owner
Holding Value $44.4M 55,816,786 shares
Last Trade
Apr 21, 2022 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$48.7M 27,982,529 shares
$1.74
$0.79
Outlook Therapeutics- Warrants
Outlook Therapeutics- Warrants OTLKW
10% owner
Holding Value $839k 27,982,529 shares
Last Trade
Feb 01, 2022 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$104k 2,500,000 shares
$0.04
$0.03
Outlook Therapeutics
Outlook Therapeutics OTLK
10% owner
Holding Value $22.2M 27,982,529 shares
Last Trade
Feb 01, 2022 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$3.73M 2,500,000 shares
$1.49
$0.79
Outlook Therapeutics
Outlook Therapeutics OTLK
10% owner
Holding Value $22.1M 27,834,257 shares
Last Trade
Nov 29, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$23M 16,000,000 shares
$1.44
$0.79
Outlook Therapeutics- Warrants
Outlook Therapeutics- Warrants OTLKW
10% owner
Holding Value $835k 27,834,257 shares
Last Trade
Nov 29, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$2.2M 16,000,000 shares
$0.14
$0.03

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up